Amelioration of Behavioural, Biochemical, and Neurophysiological Deficits by Combination of Monosodium Glutamate with Resveratrol/Alpha-Lipoic Acid/Coenzyme Q10 in Rat Model of Cisplatin-Induced Peripheral Neuropathy
Cisplatin or cis-diamminedichloroplatinum (II) (CDDP) is a cytotoxic chemotherapeutic agent with dose-dependent peripheral neuropathy as a foremost side effect characterised by ataxia, pain, and sensory impairment. Cumulative drug therapy of CDDP is known to produce severe oxidative damage. It mainl...
Saved in:
| Main Authors: | , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2013-01-01
|
| Series: | The Scientific World Journal |
| Online Access: | http://dx.doi.org/10.1155/2013/565813 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1832561284107730944 |
|---|---|
| author | Naini Bhadri Tejaswi Sanji Hariprasad Madakasira Guggilla Rema Razdan |
| author_facet | Naini Bhadri Tejaswi Sanji Hariprasad Madakasira Guggilla Rema Razdan |
| author_sort | Naini Bhadri |
| collection | DOAJ |
| description | Cisplatin or cis-diamminedichloroplatinum (II) (CDDP) is a cytotoxic chemotherapeutic agent with dose-dependent peripheral neuropathy as a foremost side effect characterised by ataxia, pain, and sensory impairment. Cumulative drug therapy of CDDP is known to produce severe oxidative damage. It mainly targets and accumulates in dorsal root ganglia that in turn cause damage resulting in secondary nerve fibre axonopathy. In the present study, we investigated the neuroprotective effect of the combination of monosodium glutamate (MSG) with three individual antioxidants, that is, resveratrol, alpha-lipoic acid (ALA), and coenzyme Q10 (CoQ10), in cisplatin (2 mg/kg i.p. twice weekly) induced peripheral neuropathy in rats. After 8 weeks of treatment the degree of neuroprotection was determined by measuring behavioral and electrophysiological properties and sciatic nerve lipid peroxidation, as well as glutathione and catalase levels. The results suggested that pretreatment with the combination of MSG (500 mg/kg/day po) with resveratrol (10 mg/kg/day i.p.) or ALA (20 mg/kg/day i.p.) or CoQ10 (10 mg/kg weekly thrice i.p.) exhibited neuroprotective effect. The maximum neuroprotection of MSG was observed in the combination with resveratrol. |
| format | Article |
| id | doaj-art-5d89efd1719b4c368700cf9cf12e394e |
| institution | Kabale University |
| issn | 1537-744X |
| language | English |
| publishDate | 2013-01-01 |
| publisher | Wiley |
| record_format | Article |
| series | The Scientific World Journal |
| spelling | doaj-art-5d89efd1719b4c368700cf9cf12e394e2025-02-03T01:25:28ZengWileyThe Scientific World Journal1537-744X2013-01-01201310.1155/2013/565813565813Amelioration of Behavioural, Biochemical, and Neurophysiological Deficits by Combination of Monosodium Glutamate with Resveratrol/Alpha-Lipoic Acid/Coenzyme Q10 in Rat Model of Cisplatin-Induced Peripheral NeuropathyNaini Bhadri0Tejaswi Sanji1Hariprasad Madakasira Guggilla2Rema Razdan3Department of Pharmacology, Al-Ameen College of Pharmacy, Bangalore, Karnataka-560027, IndiaDepartment of Pharmacology, Al-Ameen College of Pharmacy, Bangalore, Karnataka-560027, IndiaDepartment of Pharmacology, Al-Ameen College of Pharmacy, Bangalore, Karnataka-560027, IndiaDepartment of Pharmacology, Al-Ameen College of Pharmacy, Bangalore, Karnataka-560027, IndiaCisplatin or cis-diamminedichloroplatinum (II) (CDDP) is a cytotoxic chemotherapeutic agent with dose-dependent peripheral neuropathy as a foremost side effect characterised by ataxia, pain, and sensory impairment. Cumulative drug therapy of CDDP is known to produce severe oxidative damage. It mainly targets and accumulates in dorsal root ganglia that in turn cause damage resulting in secondary nerve fibre axonopathy. In the present study, we investigated the neuroprotective effect of the combination of monosodium glutamate (MSG) with three individual antioxidants, that is, resveratrol, alpha-lipoic acid (ALA), and coenzyme Q10 (CoQ10), in cisplatin (2 mg/kg i.p. twice weekly) induced peripheral neuropathy in rats. After 8 weeks of treatment the degree of neuroprotection was determined by measuring behavioral and electrophysiological properties and sciatic nerve lipid peroxidation, as well as glutathione and catalase levels. The results suggested that pretreatment with the combination of MSG (500 mg/kg/day po) with resveratrol (10 mg/kg/day i.p.) or ALA (20 mg/kg/day i.p.) or CoQ10 (10 mg/kg weekly thrice i.p.) exhibited neuroprotective effect. The maximum neuroprotection of MSG was observed in the combination with resveratrol.http://dx.doi.org/10.1155/2013/565813 |
| spellingShingle | Naini Bhadri Tejaswi Sanji Hariprasad Madakasira Guggilla Rema Razdan Amelioration of Behavioural, Biochemical, and Neurophysiological Deficits by Combination of Monosodium Glutamate with Resveratrol/Alpha-Lipoic Acid/Coenzyme Q10 in Rat Model of Cisplatin-Induced Peripheral Neuropathy The Scientific World Journal |
| title | Amelioration of Behavioural, Biochemical, and Neurophysiological Deficits by Combination of Monosodium Glutamate with Resveratrol/Alpha-Lipoic Acid/Coenzyme Q10 in Rat Model of Cisplatin-Induced Peripheral Neuropathy |
| title_full | Amelioration of Behavioural, Biochemical, and Neurophysiological Deficits by Combination of Monosodium Glutamate with Resveratrol/Alpha-Lipoic Acid/Coenzyme Q10 in Rat Model of Cisplatin-Induced Peripheral Neuropathy |
| title_fullStr | Amelioration of Behavioural, Biochemical, and Neurophysiological Deficits by Combination of Monosodium Glutamate with Resveratrol/Alpha-Lipoic Acid/Coenzyme Q10 in Rat Model of Cisplatin-Induced Peripheral Neuropathy |
| title_full_unstemmed | Amelioration of Behavioural, Biochemical, and Neurophysiological Deficits by Combination of Monosodium Glutamate with Resveratrol/Alpha-Lipoic Acid/Coenzyme Q10 in Rat Model of Cisplatin-Induced Peripheral Neuropathy |
| title_short | Amelioration of Behavioural, Biochemical, and Neurophysiological Deficits by Combination of Monosodium Glutamate with Resveratrol/Alpha-Lipoic Acid/Coenzyme Q10 in Rat Model of Cisplatin-Induced Peripheral Neuropathy |
| title_sort | amelioration of behavioural biochemical and neurophysiological deficits by combination of monosodium glutamate with resveratrol alpha lipoic acid coenzyme q10 in rat model of cisplatin induced peripheral neuropathy |
| url | http://dx.doi.org/10.1155/2013/565813 |
| work_keys_str_mv | AT nainibhadri ameliorationofbehaviouralbiochemicalandneurophysiologicaldeficitsbycombinationofmonosodiumglutamatewithresveratrolalphalipoicacidcoenzymeq10inratmodelofcisplatininducedperipheralneuropathy AT tejaswisanji ameliorationofbehaviouralbiochemicalandneurophysiologicaldeficitsbycombinationofmonosodiumglutamatewithresveratrolalphalipoicacidcoenzymeq10inratmodelofcisplatininducedperipheralneuropathy AT hariprasadmadakasiraguggilla ameliorationofbehaviouralbiochemicalandneurophysiologicaldeficitsbycombinationofmonosodiumglutamatewithresveratrolalphalipoicacidcoenzymeq10inratmodelofcisplatininducedperipheralneuropathy AT remarazdan ameliorationofbehaviouralbiochemicalandneurophysiologicaldeficitsbycombinationofmonosodiumglutamatewithresveratrolalphalipoicacidcoenzymeq10inratmodelofcisplatininducedperipheralneuropathy |